The WHO warns that the Omigron variant may “have a significant impact on the course of the epidemic”.

Published:

9 dic 2021 00:22 GMT

The director general of the company, Tetros Adanom Caprais, explained that the new strain was a “consistent picture of rapid spread increase”.

World Health Organization Director-General Tetros Adanom Capreius, Warning The Omigron variant this Wednesday will change the course of the corona virus infection.

“Some of the characteristics of Omigran, its global distribution and the large number of mutations suggest that it may have a major impact on the course of the infection. It is difficult to know exactly what its impact will be“Gabrias argued for a while Information session Held at the agency’s headquarters in Geneva (Switzerland), the new strain was detected in 57 countries, and this number is set to increase.

At the same time, he stressed that the WHO confirms the “consistent picture of rapid transmission” of the Omigron variant, although he explained that it is still difficult to determine the exact ratio with respect to other strains.

In addition, he noted, South Africa’s data suggest that Omigron increases the risk of re-infection with COVID-19. However, he insisted on waiting for more information to be found “Firm” results.

Regarding the severity of the cases, Gabrias explained that, according to the available evidence, the Omigron variant causes a disease. Low intensity Compared to the delta strain, but “it’s still too soon to be firm.”

“Now any complacency will cost lives. Many of the undead may be struggling in the long covit or post covit state, and we are beginning to understand a disease with weak and persistent symptoms,” he warned. Company.

Efficacy of vaccines against omigran

The WHO’s comments come in a context Investigation Conducted by South African scientists, its results confirmed that the protection provided by the Omigran variant Pfizer and the Biotech vaccine could be partially avoided. However, the authors of the research pointed out that the drug continues to protect against the serious occurrence of the disease.

With this in mind, WHO Chief Scientist Soumya Swaminathan, at the same press conference, assured that there is still a long way to go to ensure that the effectiveness of the existing anticoagulant components against the Omigron strain is reduced. He stressed on this.Do not make decisionsAnd work in an integrated manner in the field of science.